help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burroughs, K. D.
Right arrow Articles by Walker, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burroughs, K. D.
Right arrow Articles by Walker, C.
Endocrinology Vol. 138, No. 7 3056-3064
Copyright © 1997 by The Endocrine Society

ARTICLES

Regulation of Apoptosis in Uterine Leiomyomata1

Kevin D. Burroughs, Kaoru Kiguchi, Susan R. Howe, Robin Fuchs-Young, David Trono, J. Carl Barrett and Cheryl Walker

Department of Carcinogenesis, University of Texas M. D. Anderson Cancer Center (K.D.B., K.K., S.R.H., R.F.-Y., D.T., C.W.), Smithville, Texas 78957; Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences (J.C.B.), Research Triangle Park, North Carolina 27709

Address all correspondence and requests for reprints to: Dr. Kevin D. Burroughs, Department of Carcinogenesis, University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957.

Tumors developing from hormone-dependent tissues, such as the breast and prostate, have been successfully treated in the clinic by methods of hormone ablation, and the resulting tumor regression has been shown to occur at least in part by the process of apoptosis. The growth of leiomyomas arising from uterine smooth muscle cells is similarly modulated by circulating steroid hormones and has been associated with periods of increased estrogen secretion. The inhibition of ovarian hormone production by endocrine therapy often results in the regression of these tumors, but the role of apoptosis in this process has not been elucidated. Using cell lines derived from the Eker rat model of uterine leiomyoma, we have investigated the mechanism of growth inhibition by estrogen deprivation. Estrogen-depleted medium and the antiestrogen tamoxifen significantly reduced cell numbers in culture and arrested cell proliferation, but did not induce apoptosis. However, the presence of an intact apoptotic pathway was demonstrated in these cells by serum starvation. In vivo data were in agreement with in vitro results, which showed that tamoxifen treatment does not change the apoptotic rate of leiomyoma tissues. Therefore, growth modulation of leiomyomas by hormone deprivation occurs via mechanisms independent of apoptosis, indicating a fundamental difference in the response of leiomyomas to hormone deprivation from that of tumors of the breast and prostate. These data suggest that creation of a hypoestrogenic milieu within leiomyomas reduces tumor volume without inducing a concomitant increase in the rate of apoptosis, which may be responsible for the limited effectiveness of currently available medicinal therapies.




This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
U. A. Kayisli, M. Berkkanoglu, G. Kizilay, L. Senturk, and A. Arici
Expression of Proliferative and Preapoptotic Molecules in Human Myometrium and Leiomyoma Throughout the Menstrual Cycle
Reproductive Sciences, October 1, 2007; 14(7): 678 - 686.
[Abstract] [PDF]

Home page
 EndocrinologyHome page
M.-N. Raymond, C. Bole-Feysot, Y. Banno, Z. Tanfin, and P. Robin
Endothelin-1 Inhibits Apoptosis through a Sphingosine Kinase 1-Dependent Mechanism in Uterine Leiomyoma ELT3 Cells
Endocrinology, December 1, 2006; 147(12): 5873 - 5882.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. D. Cook, B. J. Davis, S.-L. Cai, J. C. Barrett, C. J. Conti, and C. L. Walker
Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance
PNAS, June 14, 2005; 102(24): 8644 - 8649.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
T. Maruo, N. Ohara, J. Wang, and H. Matsuo
Sex steroidal regulation of uterine leiomyoma growth and apoptosis
Hum. Reprod. Update, May 1, 2004; 10(3): 207 - 220.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S.-C. Huang, M.-J. Tang, Y.-M. Cheng, K.-F. Hsu, C.-L. Ho, and C.-Y. Chou
Enhanced Polyadenosine Diphosphate-Ribosylation in Gonadotropin-Releasing Hormone Agonist-Treated Uterine Leiomyoma
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 5009 - 5016.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S.-C. Huang, M.-J. Tang, K.-F. Hsu, Y.-M. Cheng, and C.-Y. Chou
Fas and Its Ligand, Caspases, and Bcl-2 Expression in Gonadotropin-Releasing Hormone Agonist-Treated Uterine Leiomyoma
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4580 - 4586.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
C. L. Walker
Role of Hormonal and Reproductive Factors in the Etiology and Treatment of Uterine Leiomyoma
Recent Prog. Horm. Res., January 1, 2002; 57(1): 277 - 294.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
K. D. Houston, D. S. Hunter, L. C. Hodges, and C. L. Walker
Uterine Leiomyomas: Mechanisms of Tumorigenesis
Toxicol Pathol, January 1, 2001; 29(1): 100 - 104.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. D. Gamage, E. D. Bischoff, K. D. Burroughs, W. W. Lamph, M. M. Gottardis, C. L. Walker, and R. Fuchs-Young
Efficacy of LGD1069 (Targretin), a Retinoid X Receptor-Selective Ligand, for Treatment of Uterine Leiomyoma
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 677 - 681.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
K. D. Burroughs, R. Fuchs-Young, B. Davis, and C. L. Walker
Altered Hormonal Responsiveness of Proliferation and Apoptosis During Myometrial Maturation and the Development of Uterine Leiomyomas in the Rat
Biol Reprod, November 1, 2000; 63(5): 1322 - 1330.
[Abstract] [Full Text]

Home page
 Reproductive SciencesHome page
C. L. Walker, K. D. Burroughs, B. Davis, K. Sowell, J. I. Everitt, and R. Fuchs-Young
Preclinical Evidence for Therapeutic Efficacy of Selective Estrogen receptor Modulators for Uterine Leiomyoma
Reproductive Sciences, July 1, 2000; 7(4): 249 - 256.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. J. Hamann, J. E. Vieira, A. J. Halayko, D. Dorscheid, S. R. White, S. M. Forsythe, B. Camoretti-Mercado, K. F. Rabe, and J. Solway
Fas cross-linking induces apoptosis in human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L618 - L624.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Benassayag, M. J. Leroy, V. Rigourd, B. Robert, J. C. Honore, T. M. Mignot, M. C. Vacher-Lavenu, C. Chapron, and F. Ferre
Estrogen receptors (ERalpha /ERbeta ) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma
Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1112 - E1118.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society